Erin Allman‑Updyke
speaker
549 appearances
1 recordings
1 series
first heard Sep 2026
last heard 8 Sep
Erin Allman‑Updyke’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Sep 2026 with 1.
Appearances
And this actually induces neurotrophic.
genesis.
And so we think maybe it's down to that.
Maybe it's some combination of all of these different things that are all happening as a result of ECT.
And we don't necessarily have like a one-to-one mechanism of like this is the thing that helps with depression.
This is the thing that helps with suicidality.
This is the thing, you know, we don't we don't necessarily know.
Certainly no.
And there probably isn't, right?
Like the things that cause psychosis in schizophrenia are probably not exactly the same things that are causing treatment resistant depression, right?
That doesn't make sense that those are the same exact thing, but we can treat both of them with something like ECT.
So it it's really interesting.
And and really, like we talked about last week, Erin.
ECT works.
It is remarkably effective.
One of the main indications for ECT, one of the main reasons that we use it, especially here in the States and in a lot of, you know, European countries and Australia and New Zealand is treatment-resistant depression.
And that can be depression with or without psychosis and with or without suicidal ideation.
It can be unipolar or bipolar depression.
But most of the studies on remission and response rates are remarkable.
We can see anywhere from like 50 to 60% or more remission, meaning you have essentially no depressive symptoms, like you have gone into quote-unquote remission.
Showing 241–260 of 549 · page 13 of 28
← Previous
Next →